Abstract: A quick coupler for connecting an implement to a machine. The quick coupler including a frame, a first jaw pivotally connected to the frame and movable between an open position and a closed position, a second jaw pivotally connected to the frame and movable between an open position and a closed position, and a lock system connected to the first jaw and the second jaw. The lock system includes a first linkage pivotally connected to the frame and to the first jaw, a second linkage pivotally connected to the first linkage and to the second jaw, and a drive member connected to the first linkage and configured to selectively operate the lock system between an unlocked position and a locked position.

Abstract: A quick coupler for connecting an implement to a machine, the implement having a connection pin, the quick coupler, including a frame, includes a jaw pivotally connected to the frame and movable between an open position and a closed position, the jaw configured to cooperate with the connection pin of the implement. The quick coupler also including a lock pivotally connected to the frame and movable between an unlocked position and a locked position, the lock including a pawl configured to cooperate with a detent on the jaw. The quick coupler including a release mechanism connected to the frame and to the lock, wherein the jaw in the closed position and the lock in the locked position define a load path, the release mechanism being positioned outside the load path.

Abstract: A quick coupler for connecting an implement to a machine. The quick coupler including a frame, a first jaw pivotally connected to the frame and movable between an open position and a closed position, a second jaw pivotally connected to the frame and movable between an open position and a closed position, and a lock system connected to the first jaw and the second jaw. The lock system includes a first linkage pivotally connected to the frame and to the first jaw, a second linkage pivotally connected to the first linkage and to the second jaw, and a drive member connected to the first linkage and configured to selectively operate the lock system between an unlocked position and a locked position.

Abstract: The present invention relates to flea peritrophin proteins; to flea peritrophin nucleic acid molecules, including those that encode such flea peritrophin proteins; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain and use such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes therapeutic compositions comprising such inhibitory compounds, particularly those that specifically inhibit flea peritrophin activity, as well as the use of such therapeutic compositions to treat animals.

Abstract: The present invention relates to flea head, nerve cord, hindgut and Malpighian tubule proteins; to flea head, nerve cord, hindgut and Malpighian tubule nucleic acid molecules, including those that encode such flea head, nerve cord, hindgut and Malpighian tubule proteins; to antibodies raised against such flea head, nerve cord, hindgut and Malpighian tubule proteins; and to compounds that inhibit flea head, nerve cord, hindgut and Malpighian tubule protein activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising proteins, nucleic acid molecules, antibodies, or protective compounds derived from proteins of the present invention as well as the use of such therapeutic compositions to protect animals from flea infestation.

Abstract: The present invention relates to flea head, nerve cord, hindgut and Malpighian tubule proteins; to flea head, nerve cord, hindgut and Malpighian tubule nucleic acid molecules, including those that encode such flea head, nerve cord, hindgut and Malpighian tubule proteins; to antibodies raised against such flea head, nerve cord, hindgut and Malpighian tubule proteins; and to compounds that inhibit flea head, nerve cord, hindgut and Malpighian tubule protein activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising proteins, nucleic acid molecules, or protective compounds derived from proteins of the present invention as well as the use of such therapeutic compositions to protect animals from flea infestation.

Abstract: The present invention relates to flea allantoinase proteins; to flea allantoinase nucleic acid molecules, including those that encode such flea allantoinase proteins; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes therapeutic compositions comprising such inhibitory compounds, particularly those that specifically inhibit flea allantoinase activity, as well as the use of such therapeutic compositions to treat animals.

Abstract: The present invention relates to flea allantoinase proteins; to flea allantoinase nucleic acid molecules, including those that encode such flea allantoinase proteins; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes therapeutic compositions comprising such inhibitory compounds, particularly those that specifically inhibit flea allantoinase activity, as well as the use of such therapeutic compositions to treat animals.

Abstract: The present invention relates to flea synaptic vesicle proteins; to flea synaptic vesicle nucleic acid molecules, including those that encode such flea synaptic vesicle proteins, respectively; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes therapeutic compositions comprising such inhibitory compounds, particularly those that specifically inhibit flea synaptic vesicle activity, as well as the use of such therapeutic compositions to treat animals.

Abstract: The cooling system for a skid steer loader provides a unitary assembly that is pivotally mounted to the body portion of the loader above the engine. The unitary assembly includes a frame, first and second heat exchangers, a shroud, a guard, a drive mechanism, and a fan. During times of maintenance on the work machine the entire cooling system can be moved to a second position providing unencumbered access to the engine compartment.